Urine and serum free IGF-1 levels in patients with bladder cancer: A brief report

Urological Research

Volumn 31, Issue 5, 2003, Pages 297-299

  Serel, T Ahmet ^a   Turan, Tahir ^b   Soyupek, Sedat ^a   Aybek, Zafer ^b   Perk, Hakki ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Bladder cancer; Free insulin like growth factor 1

Indexed keywords

SOMATOMEDIN C;

ADULT; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; COVARIANCE; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANK SUM TEST; STATISTICAL ANALYSIS; URINE LEVEL;

HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0242485299     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-003-0335-0     Document Type: Article

References (22)

1. Bereket A, Lang CH, Blethen SL, Kaskel FJ, Stewart C, Wilson TA (1997) Growth hormone treatment in growth retarded children with end-stage renal failure: effect on free/ dissociable IGF-I levels. J Pediatr Endocrinol Metab 10: 197
2. Byrne RL, Leung H, Neal DE (1996) Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 77: 627
3. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563
4. Cohen P, Peehl DM, Lamson G, Rosenfeld RG (1991) Insulin-like growth factors, IGF receptors and IGF binding proteins in primary culture of prostate epithelial cells. J Clin Endocrinol Metabol 73: 401
5. Daughaday WH (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127: 1
6. Goodman-Gruen D, Barrett-Conor E (1997) Epidemiology of insulin-like growth factor-1 in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145: 970
7. Guler HP, Zapf J, Froesch ER (1987) Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317: 137
8. Hirscberg R (1996) Insulin-like growth factor in the kidney. Miner Electrolyte Metab 22: 128
9. Iwamura M, Ishibe M, Sluss PM, Cockett ATK (1993) Characterization of insulin-like growth factor binding sites in human bladder cancer cell lines. Urol Res 21: 27
10. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE (1994) Serum insulin-like growth factor-1 in 1,030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78: 744
11. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Muller J, Skakkebaek NE (1997) Free insulin-like growth factor I serum levels in 1,430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82: 2497
12. Kirschner BS, Sutton MM (1986) Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91: 830
13. Laiho M, Keski-Oja J (1989) Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49: 2533
14. Li SL, Goko H, Xu ZD, Kimura G, Sun Y, Kawachi MH, Wilson TG, Wilczynski S, Fujita-Yamaguchi Y (1998) Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder and paraganglioma tumors. Cell Tissue Res 291: 469
15. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91: 620
16. Miles LEM, Lipschitz DA, Bieber CP, Cook JD (1974) Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 61: 209
17. Samani AA, Brodt P.(2001) The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis. Surg Oncol Clin N Am 10: 289
18. Shimasaki S, Ling N (1991) Identification and molecular characterisation of insulin-like growth factor binding proteins. Prog Growth Factor Res 3: 243
19. Werner H, Karnieli E, Rauscher FJIII, LeRoith D (1996) Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci Washington 93: 8318
20. Wu JC, Daughaday WH, Lee SD, Hsiao TS, Chou CK, Lin HD, Tsai YT, Chiang BN (1988) Radioimmunoassay of serum IGF-1 and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglicemia. J Lab Clin Med 112: 589
21. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91: 151
22. Zapf J, Hauri C, Waldvogel M, Froesch ER (1986) Acute metabolic effects and half-lives of intravenously administered insulin like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 77: 1768